These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21274873)

  • 1. B cell depletion therapy exacerbates murine primary biliary cirrhosis.
    Dhirapong A; Lleo A; Yang GX; Tsuneyama K; Dunn R; Kehry M; Packard TA; Cambier JC; Liu FT; Lindor K; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2011 Feb; 53(2):527-35. PubMed ID: 21274873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.
    Moritoki Y; Tsuneyama K; Nakamura Y; Kikuchi K; Shiota A; Ohsugi Y; Lian ZX; Zhang W; Yang GX; Ueki S; Takeda M; Omokawa A; Saga T; Saga A; Watanabe D; Miura M; Ueno Y; Leung PSC; Tanaka A; Gershwin ME; Hirokawa M
    Front Immunol; 2018; 9():2534. PubMed ID: 30450101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
    Moritoki Y; Lian ZX; Lindor K; Tuscano J; Tsuneyama K; Zhang W; Ueno Y; Dunn R; Kehry M; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Dec; 50(6):1893-903. PubMed ID: 19877182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
    Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
    J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Takahashi T; Miura T; Nakamura J; Yamada S; Miura T; Yanagi M; Matsuda Y; Usuda H; Emura I; Tsuneyama K; He XS; Gershwin ME
    Hepatology; 2012 Mar; 55(3):846-55. PubMed ID: 22031474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
    Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
    Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.
    Jin Q; Moritoki Y; Lleo A; Tsuneyama K; Invernizzi P; Moritoki H; Kikuchi K; Lian ZX; Hirschfield GM; Ansari AA; Coppel RL; Gershwin ME; Niu J
    Hepatology; 2012 May; 55(5):1495-506. PubMed ID: 22135136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.
    Lleo A; Bowlus CL; Yang GX; Invernizzi P; Podda M; Van de Water J; Ansari AA; Coppel RL; Worman HJ; Gores GJ; Gershwin ME
    Hepatology; 2010 Sep; 52(3):987-98. PubMed ID: 20568301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.
    Chang CH; Chen YC; Yu YH; Tao MH; Leung PS; Ansari AA; Gershwin ME; Chuang YH
    Clin Exp Immunol; 2014 Aug; 177(2):373-80. PubMed ID: 24547942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of primary biliary cirrhosis: materials and methods.
    Leung PS; Yang GX; Dhirapong A; Tsuneyama K; Ridgway WM; Gershwin ME
    Methods Mol Biol; 2012; 900():291-316. PubMed ID: 22933075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental basis of primary biliary cholangitis.
    Tanaka A; Leung PS; Gershwin ME
    Exp Biol Med (Maywood); 2018 Jan; 243(2):184-189. PubMed ID: 29307284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual B-cell targeting therapy ameliorates autoimmune cholangitis.
    Zhang W; Shao T; Leung PSC; Tsuneyama K; Heuer L; Young HA; Ridgway WM; Gershwin ME
    J Autoimmun; 2022 Oct; 132():102897. PubMed ID: 36029718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis.
    Dhirapong A; Yang GX; Nadler S; Zhang W; Tsuneyama K; Leung P; Knechtle S; Ansari AA; Coppel RL; Liu FT; He XS; Gershwin ME
    Hepatology; 2013 Feb; 57(2):708-15. PubMed ID: 22996325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
    Hsueh YH; Chen HW; Syu BJ; Lin CI; Leung PSC; Gershwin ME; Chuang YH
    J Autoimmun; 2018 Dec; 95():159-170. PubMed ID: 30274824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis.
    Tanaka H; Yang GX; Iwakoshi N; Knechtle SJ; Kawata K; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Joh T; Bowlus C; Gershwin ME
    Clin Exp Immunol; 2013 Dec; 174(3):364-71. PubMed ID: 23981074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.
    Li Y; Wang W; Tang L; He X; Yan X; Zhang X; Zhu Y; Sun J; Shi Y; Ma X; Mackay IR; Gershwin ME; Han Y; Hou J
    Hepatology; 2015 Jun; 61(6):1998-2007. PubMed ID: 25627620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
    Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
    PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.